All terms in GO
| Label | Id | Description |
|---|---|---|
| interleukin-22 binding | GO_0042017 |
Binding to interleukin-22.
|
| 5-aminolevulinic acid import across plasma membrane | GO_0140484 |
The directed movement of 5-aminolevulinic acid from outside of a cell, across the plasma membrane and into the cytosol.
|
| interleukin-20 receptor activity | GO_0042016 |
Combining with interleukin-20 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
|
| obsolete negative regulation of interleukin-14 production | GO_0032697 |
OBSOLETE. Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-14 production.
|
| FH1 domain binding | GO_0017058 |
Binding to a FH1 domain of a protein, a proline-rich domain, usually located in front of a FH2 domain.
|
| 6-phosphogluconolactonase activity | GO_0017057 |
Catalysis of the reaction: 6-O-phosphono-D-glucono-1,5-lactone + H(2)O = 6-phospho-D-gluconate + H(+).
|
| structural constituent of nuclear pore | GO_0017056 |
The action of a molecule that contributes to the structural integrity of the nuclear pore complex, a protein-lined channel in the nuclear envelope that allows the transfer of macromolecules.
|
| negative regulation of RNA polymerase II transcription preinitiation complex assembly | GO_0017055 |
Any process that stops, prevents, or reduces the frequency, rate or extent of RNA polymerase II transcriptional preinitiation complex assembly.
|
| negative cofactor 2 complex | GO_0017054 |
A heterodimeric protein complex that can stably associate with TATA-binding protein on promoters, thereby preventing the assembly of transcription factors TFIIA and TFIIB and leading to repression of RNA polymerase II transcription. The two subunits, NC2alpha (Drap1) and NC2beta (Dr1), dimerize through histone fold domains of the H2A/H2B type present in the amino termini.
|
| negative regulation of interleukin-1 alpha production | GO_0032690 |
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-1 alpha production.
|
| obsolete insulin-like growth factor binding protein | GO_0017052 |
OBSOLETE. (Was not defined before being made obsolete).
|
| S-methyl-5-thioadenosine phosphorylase activity | GO_0017061 |
Catalysis of the reaction: 5'-methylthioadenosine + phosphate = adenine + 5-methylthio-D-ribose 1-phosphate.
|
| 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity | GO_0017060 |
Catalysis of the reaction: GDP-L-fucose + beta-D-galactosyl-(1,3)-N-acetyl-D-glucosaminyl-R = GDP + beta-D-galactosyl-(1,3)-[alpha-L-fucosyl-(1,4)]-N-acetyl-D-glucosaminyl-R.
|
| interleukin-20 binding | GO_0042015 |
Binding to interleukin-20.
|
| negative regulation of interleukin-16 production | GO_0032699 |
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-16 production.
|
| interleukin-19 receptor activity | GO_0042014 |
Combining with interleukin-19 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
|
| interleukin-19 binding | GO_0042013 |
Binding to interleukin-19.
|
| heme receptor activity | GO_0140488 |
Binding specifically to heme to deliver it to a transport vesicle.
|
| interleukin-16 receptor activity | GO_0042012 |
Combining with interleukin-16 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
|
| interleukin-16 binding | GO_0042011 |
Binding to interleukin-16.
|